IVX-0142

a heparin-derived hypersulfated disaccharide devoid of anticoagulant activity while possessing anti-allergic and anti-inflammatory activity

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Inflammation (Inflammations) 09/01/2008 - "The effect of a single nebulized dose of IVX-0142 (80 mg) or placebo administered 30 min prior to allergen inhalation was evaluated on the allergic airway responses, airway responsiveness, and airway inflammation. "
2.	Asthma (Bronchial Asthma) 09/01/2008 - "In a proof-of-concept study, the allergen inhalation challenge model was used to investigate the effect of IVX-0142 in mild atopic asthma. " 09/01/2008 - "The effect of IVX-0142, a heparin-derived hypersulfated disaccharide, on the allergic airway responses in asthma."